5AR1 Stock Chart & Stats
€0.58
-€0.07(-21.17%)
At close: 4:00 PM EDT
€0.58
-€0.07(-21.17%)
Day’s Range― - ―
52-Week Range€0.24 - €2.54
Previous CloseN/A
Volume0.00
Average Volume (3M)1.96K
Market Cap
€61.68M
Enterprise Value€185.74
Total Cash (Recent Filing)€5.85M
Total Debt (Recent Filing)€28.59M
Price to Earnings (P/E)―
Beta0.93
Next Earnings
Mar 26, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.14
Shares Outstanding139,836,520
10 Day Avg. Volume40
30 Day Avg. Volume1,960
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.06
Price to Sales (P/S)2.63
P/FCF Ratio-0.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.51
Revenue Forecast (FY)€30.32M
Bulls Say, Bears Say
Bulls Say
Low LeverageVery low debt relative to equity gives AI Financial greater financial flexibility than a highly leveraged software company. This reduces near-term solvency and interest-burden risk, allowing more time to address operating losses, although it does not by itself create sustainable profitability.
Secured Divestiture ConsiderationThe completed divestiture converts the subsidiary into a creditor position and an equity stake in the buyer, creating potential financial resources beyond ongoing operations. The secured note, guarantees, interest payments, and staged repayment terms provide defined consideration and some downside protection.
Positive Gross MarginPositive gross margin indicates the company’s offerings generate value above direct costs, providing a foundation for eventual operating improvement. If revenue stabilizes and expenses become better aligned with gross profit, this underlying contribution could support improved earnings and cash generation over time.
Bears Say
Declining RevenueA material TTM revenue decline signals weakening demand, customer adoption, or business scale and reduces the base from which fixed costs can be absorbed. Continued contraction would make operating leverage harder to achieve and could limit investment capacity while management works to restore growth.
Deep Operating LossesLarge operating and EBITDA losses show that gross profit is not covering the company’s broader cost structure, while the very large net loss highlights substantial earnings volatility. Persistent losses can consume resources, constrain reinvestment, and make a durable path to profitability more difficult.
Negative Cash GenerationNegative operating and free cash flow means the business is not currently self-funding its operations, even though free cash flow was positive in 2023–2024. Sustained cash burn can reduce financial flexibility and increase reliance on asset sales, financing, or other external funding.
AI Financial Corporation News
5AR1 FAQ
What was AI Financial Corporation’s price range in the past 12 months?
AI Financial Corporation lowest stock price was €0.24 and its highest was €2.54 in the past 12 months.
What is AI Financial Corporation’s market cap?
AI Financial Corporation’s market cap is €61.68M.
When is AI Financial Corporation’s upcoming earnings report date?
AI Financial Corporation’s upcoming earnings report date is Mar 26, 2027 which is in 173 days.
How were AI Financial Corporation’s earnings last quarter?
AI Financial Corporation released its earnings results on Apr 13, 2026. The company reported -€1.902 earnings per share for the quarter, missing the consensus estimate of -€0.16 by -€1.742.
Is AI Financial Corporation overvalued?
According to Wall Street analysts AI Financial Corporation’s price is currently Overvalued.
Does AI Financial Corporation pay dividends?
AI Financial Corporation does not currently pay dividends.
What is AI Financial Corporation’s EPS estimate?
AI Financial Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AI Financial Corporation have?
AI Financial Corporation has 139,836,520 shares outstanding.
What happened to AI Financial Corporation’s price movement after its last earnings report?
AI Financial Corporation reported an EPS of -€1.902 in its last earnings report, missing expectations of -€0.16. Following the earnings report the stock price went up 6.32%.
Which hedge fund is a major shareholder of AI Financial Corporation?
Currently, no hedge funds are holding shares in DE:5AR1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AI Financial Corporation Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-81.90%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
664.78%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
AI Financial Corporation
AI Financial Corporation, a global entity operating through its various subsidiaries, specializes in distributed ledger technology solutions. The company's activities are strategically divided into two primary segments: Fintech and Biotechnology. Its Fintech division manages the entire ecosystem of digital assets, covering everything from their initial creation (tokenization) to their trading, clearing, settlement, payment processing, and secure safekeeping. Within this sector, AI Financial offers significant products such as ALT 5 Prime, a sophisticated electronic over-the-counter (OTC) trading platform designed for the acquisition and divestiture of digital assets. Another key offering is ALT 5 Pay, a cryptocurrency payment gateway that empowers merchants to either accept and disburse payments in digital currencies directly or integrate this capability into their existing software applications. The biotechnology arm is dedicated to identifying, procuring, licensing, advancing, collaborating on, and commercializing innovative, non-opioid, and non-addictive therapeutic solutions for addressing pain and addiction. Noteworthy projects include JAN 101, an orally administered, sustained-release sodium nitrite compound that has successfully concluded Phase 2a clinical trials for the treatment of peripheral arterial disease and pain. Additionally, the company is developing JAN123, a low-dose naltrexone formulation specifically tailored for managing chronic regional pain syndrome. Established in 1976, the company is based in Las Vegas, Nevada. It officially adopted its current name, AI Financial Corporation, in April 2026, having previously been known as ALT5 Sigma Corporation.